Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
HC-1902 by CSPC Zhongnuo Pharmaceutical (Shijiazhuang) for Hypertension: Likelihood of Approval
HC-1902 is under clinical development by CSPC Zhongnuo Pharmaceutical (Shijiazhuang) and currently in Phase III for Hypertension. According to GlobalData,...